Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 582.05 | 512.81 | 440.16 | 389.14 |
Total Revenue | 582.05 | 512.81 | 440.16 | 389.14 |
Costof Revenue Total | 184.53 | 184.52 | 162.90 | 148.91 |
Gross Profit | 397.52 | 328.29 | 277.26 | 240.23 |
Selling/ General/ Admin Expenses Total | 132.15 | 224.82 | 187.10 | 158.19 |
Depreciation/ Amortization | 17.07 | 15.50 | 15.66 | 16.47 |
Other Operating Expenses Total | 137.22 | - | 3.80 | 12.10 |
Total Operating Expense | 470.97 | 424.84 | 369.46 | 335.67 |
Operating Income | 111.08 | 87.97 | 70.70 | 53.47 |
Interest Inc( Exp) Net- Non- Op Total | -4.50 | -3.10 | 24.30 | -0.70 |
Other Net | 7.21 | 4.80 | 0.04 | 0.19 |
Net Income Before Taxes | 117.84 | 91.68 | 73.17 | 53.58 |
Provisionfor Income Taxes | 30.18 | 24.04 | 21.69 | 13.58 |
Net Income After Taxes | 87.66 | 67.64 | 51.48 | 40.00 |
Net Income Before Extra Items | 87.66 | 67.64 | 51.48 | 40.00 |
Net Income | 87.66 | 67.64 | 51.48 | 40.00 |
Income Availableto Com Excl Extra Ord | 87.66 | 67.64 | 51.48 | 40.00 |
Income Availableto Com Incl Extra Ord | 87.66 | 67.64 | 51.48 | 40.00 |
Diluted Net Income | 87.66 | 67.64 | 51.48 | 40.00 |
Diluted Weighted Average Shares | 1.65 | 1.65 | 1.65 | 1.65 |
Diluted EPS Excluding Extra Ord Items | 53.01 | 40.90 | 31.13 | 24.19 |
DPS- Common Stock Primary Issue | 16.00 | 12.00 | 9.60 | 7.20 |
Diluted Normalized EPS | 53.01 | 41.25 | 31.13 | 24.19 |
Gain( Loss)on Saleof Assets | - | -7.80 | 0.00 | -0.10 |
Unusual Expense( Income) | - | - | - | 0.00 |
RPG Life Sciences Dividend RPG Life Sciences Bonus RPG Life Sciences News RPG Life Sciences AGM RPG Life Sciences Rights RPG Life Sciences Splits RPG Life Sciences Board Meetings RPG Life Sciences Key Metrics RPG Life Sciences Shareholdings RPG Life Sciences Balance Sheet RPG Life Sciences Cashflow RPG Life Sciences Q1 Results RPG Life Sciences Q2 Results RPG Life Sciences Q3 Results RPG Life Sciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks